Autophagy modulation as a potential therapeutic target for diverse diseases

David C. Rubinsztein, Patrice Codogno, Beth Levine

Research output: Contribution to journalArticle

786 Citations (Scopus)

Abstract

Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.

Original languageEnglish (US)
Pages (from-to)709-730
Number of pages22
JournalNature Reviews Drug Discovery
Volume11
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Autophagy
Cytoplasm
Lysosomes
Neurodegenerative Diseases
Quality Control
Organelles
Communicable Diseases
Therapeutics
Neoplasms
Autophagosomes
Protein Aggregates

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Autophagy modulation as a potential therapeutic target for diverse diseases. / Rubinsztein, David C.; Codogno, Patrice; Levine, Beth.

In: Nature Reviews Drug Discovery, Vol. 11, No. 9, 09.2012, p. 709-730.

Research output: Contribution to journalArticle

Rubinsztein, David C. ; Codogno, Patrice ; Levine, Beth. / Autophagy modulation as a potential therapeutic target for diverse diseases. In: Nature Reviews Drug Discovery. 2012 ; Vol. 11, No. 9. pp. 709-730.
@article{4a8a1a4536c24638ab49804049ad242e,
title = "Autophagy modulation as a potential therapeutic target for diverse diseases",
abstract = "Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.",
author = "Rubinsztein, {David C.} and Patrice Codogno and Beth Levine",
year = "2012",
month = "9",
doi = "10.1038/nrd3802",
language = "English (US)",
volume = "11",
pages = "709--730",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Autophagy modulation as a potential therapeutic target for diverse diseases

AU - Rubinsztein, David C.

AU - Codogno, Patrice

AU - Levine, Beth

PY - 2012/9

Y1 - 2012/9

N2 - Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.

AB - Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.

UR - http://www.scopus.com/inward/record.url?scp=84866122688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866122688&partnerID=8YFLogxK

U2 - 10.1038/nrd3802

DO - 10.1038/nrd3802

M3 - Article

VL - 11

SP - 709

EP - 730

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 9

ER -